| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/12/1994 | EP0577699A1 Compositions and methods to inhibit the activation of active factor xiii |
| 01/12/1994 | EP0577682A1 Small peptidic compounds useful for the treatment of glaucoma |
| 01/12/1994 | EP0463101B1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 01/12/1994 | EP0309566B1 Stlv-iii-related polypeptides, diagnostic systems and assay methods |
| 01/11/1994 | US5277893 Direct radiolabeling of substrates containing monosulfides or disulfide bonds with radionuclides |
| 01/11/1994 | US5277892 Administering a mixture of a lectin and a linked imaging ion |
| 01/11/1994 | CA1326109C Sv40 expression vector containing hbxag as an expression marker |
| 01/06/1994 | WO1994000509A1 Oxazolone derived materials |
| 01/06/1994 | WO1994000492A1 Angiotensin iv peptides and receptor |
| 01/06/1994 | WO1994000489A2 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
| 01/06/1994 | WO1994000486A1 Neuropeptide y antagonists |
| 01/06/1994 | WO1994000475A1 N-acetylglucosaminyltransferase v coding sequences |
| 01/06/1994 | WO1994000440A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/06/1994 | WO1994000150A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 01/06/1994 | WO1994000148A1 Synthetic peptides for the treatment of myasthenia gravis |
| 01/06/1994 | WO1994000144A1 Anti-aggregatory agents for platelets |
| 01/06/1994 | CA2139350A1 Oxazolone derived materials |
| 01/06/1994 | CA2139105A1 Angiotensin iv peptides and receptor |
| 01/06/1994 | CA2138374A1 Neuropeptide y antagonists |
| 01/05/1994 | EP0577544A1 Novel cyclosporins having modifications at position 1 |
| 01/05/1994 | EP0577394A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/05/1994 | EP0577257A1 Alpha-amylase from hyperthermophilic archaebacterium |
| 01/05/1994 | EP0576898A2 Linear peptides |
| 01/05/1994 | EP0576842A2 Method and means for detecting listeria |
| 01/05/1994 | EP0576589A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 01/04/1994 | US5276136 Laminin A chain polypeptides from the amino terminal globular domain |
| 12/30/1993 | CA2099233A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 12/29/1993 | EP0575522A1 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
| 12/29/1993 | EP0575490A1 GnRH ANALOGS |
| 12/29/1993 | EP0538398A4 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
| 12/29/1993 | EP0455682B1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides |
| 12/29/1993 | EP0386045B1 Derivatives of type a and type b synergimycins |
| 12/28/1993 | CA1325612C Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 12/28/1993 | CA1325610C Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
| 12/23/1993 | WO1993025581A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 12/23/1993 | WO1993025580A1 Cyclic peptides that modulate endothelin activity |
| 12/23/1993 | WO1993025577A2 Active component of parathyroid hypertensive factor |
| 12/23/1993 | WO1993025576A2 Peptides having platelet-derived growth factor (pdgf) activity |
| 12/23/1993 | WO1993025575A1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus |
| 12/23/1993 | WO1993025244A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 12/23/1993 | WO1993025217A1 Des-tyr dynorphin analogues |
| 12/23/1993 | CA2137916A1 Des-tyr dynorphin analogues |
| 12/23/1993 | CA2137829A1 Active component of parathyroid hypertensive factor |
| 12/23/1993 | CA2137814A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 12/23/1993 | CA2137367A1 Peptides having platelet-derived growth factor (pdgf) activity |
| 12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| 12/21/1993 | US5272252 Synthetic lung surfactant having antioxidant properties |
| 12/21/1993 | US5272151 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
| 12/19/1993 | CA2098655A1 Bradykinin antagonist peptidic derivatives, process for preparing them and phamaceutical compositions containing same |
| 12/19/1993 | CA2098535A1 Linear peptides |
| 12/15/1993 | EP0574048A2 Peptides and nucleic acid sequences related to Epstein Barr Virus |
| 12/15/1993 | EP0573608A1 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 12/15/1993 | EP0573603A1 Inhibitors of human neutrophil elastase and human cathepsin g |
| 12/15/1993 | EP0573545A1 Monoclonal antibodies against receptor-induced binding sites |
| 12/15/1993 | EP0573499A1 Process for the phosphorylation of insulin and product produced thereby. |
| 12/15/1993 | CN1079475A Extraction and use of toxin of tiger veins bird-catching spider |
| 12/15/1993 | CA2060537A1 Msh peptide derivatives |
| 12/14/1993 | US5270171 Cancer-associated SCM-recognition factor, preparation and method of use |
| 12/14/1993 | US5270030 Fibrin binding domain polypeptide and method of producing |
| 12/14/1993 | CA1325193C Class i mhc modulation of surface receptor activity |
| 12/09/1993 | WO1993024527A1 Peptide inhibitors of selectin binding |
| 12/09/1993 | WO1993024526A1 Peptide inhibitors of selectin binding |
| 12/09/1993 | WO1993024525A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 12/09/1993 | WO1993024524A1 Single chain peptide compounds having hemoregulatory activity |
| 12/09/1993 | WO1993024523A1 Double chain peptide compounds having hemoregulatory activity |
| 12/09/1993 | WO1993024522A1 Double chain peptide compounds having hemoregulatory activity |
| 12/09/1993 | WO1993024521A1 Bpc peptides, their preparation and use |
| 12/09/1993 | WO1993024520A1 Conformationally restrained peptide analogs as antiplatelet agents |
| 12/09/1993 | WO1993024518A1 Design and synthesis of a cd4 beta-turn mimetic for inhibiting the binding of hiv gp120 |
| 12/09/1993 | WO1993024138A1 Biologically active peptides having n-terminal substitutions |
| 12/09/1993 | CA2137087A1 Biologically active peptides having n-terminal substitutions |
| 12/09/1993 | CA2136844A1 Peptide inhibitors of selectin binding |
| 12/09/1993 | CA2136624A1 Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes |
| 12/09/1993 | CA2136428A1 Peptide inhibitors of selectin binding |
| 12/08/1993 | EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy |
| 12/08/1993 | EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals |
| 12/08/1993 | EP0572505A1 Human platelet-derived growth factor receptors |
| 12/08/1993 | EP0261224B1 Synthetic htlv-iii peptides, compositions and uses thereof |
| 12/07/1993 | US5268454 Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier |
| 12/07/1993 | US5268360 Opioid peptides derived from wheat proteins |
| 12/07/1993 | US5268359 Human tachykinins and their precursor |
| 12/07/1993 | US5268164 Intravascular administering a oligopeptide |
| 12/07/1993 | CA1324954C Inhibition of cell migration with synthetic peptides |
| 12/04/1993 | CA2097533A1 Peptides having neuroprotective and immunostimulatory functions |
| 12/01/1993 | EP0571921A2 Cyclopeptides and their use as resorption enhancers in mucous use |
| 12/01/1993 | EP0571549A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 12/01/1993 | EP0329761B1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 11/30/1993 | US5266684 Polypeptides |
| 11/30/1993 | US5266562 Anti-inflammatory agents |
| 11/27/1993 | CA2096889A1 Cyclopeptides and their use as absorption promoters when applied to the mucosa |
| 11/25/1993 | WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/25/1993 | WO1993023426A1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method |
| 11/25/1993 | WO1993023425A1 Metal chelating peptide |
| 11/25/1993 | WO1993023424A1 Derivatives of dolastatin |
| 11/25/1993 | WO1993023085A1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
| 11/25/1993 | WO1993019178A3 Peptides useful for inducing tolerance |
| 11/25/1993 | CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/24/1993 | EP0570829A1 Pharmaceutical composition for intravenous administration containing cyclosporin and method for its preparation |
| 11/24/1993 | EP0570509A1 Htlv-i and htlv-ii peptide antigens and methods |
| 11/24/1993 | EP0570493A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |